Blood Cancer Discovery Issues Research Articles in September 2022 Edition
November 07, 2022
November 07, 2022
PHILADELPHIA, Pennsylvania, Nov. 7 -- Blood Cancer Discovery, a peer reviewed journal from the American Association for Cancer Research that says it covers advances in basic, translational and clinical research of leukemia, lymphoma, myeloma and associated diseases, posted research articles on the following topics in its September 2022 quarterly edition:
Research Brief:
* Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Cil . . .
Research Brief:
* Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Cil . . .